Search for: "MERCK & CO." Results 841 - 860 of 1,266
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
1 Jul 2009, 7:14 am
OHIM decision in Laboratorios Andrómaco, S.A. v OTC Pharma International B V (Class 46) India: Valgancyclovir hearings and the need for more transparency: Roche v Cipla (Spicy IP) Japan approves first follow-on biologic (Patent Docs) UK: Journal of Intellectual Property Law & Practice note on ‘Paediatric extensions: the requirement of a compliance statement’ on UK IPO decision in Merck and Co, Inc (The SPC Blog) US: Sen Nelson introduces s… [read post]
23 Jun 2009, 2:44 pm
  Merck Statement in Response to the FDA's June 12, 2009 Communication with Updated Information on Leukotriene Inhibitors, Including SINGULAIR ® (montelukast sodium) -- June 12, 2009 press release from Merck & Co., Inc. [read post]
23 Jun 2009, 9:46 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Eloxatin (Oxaliplatin) – US: District Court New Jersey grants summary judgment of non-infringement in favour of Hospira, Teva and others concerning patent relating to Sanofi’s Eloxatin: Sanofi-Aventis v Sandoz (SmartBrief) (The IP Factor) (GenericsWeb) (Patents4Life) General Europe’s ever changing landscape Pirate Party,… [read post]
12 Jun 2009, 12:33 pm
This family of drugs includes zileuton, marketed by Cornerstone as Zyflo and Zyflo CR; zarfirlukast, marketed by AstraZeneca as Accolate; and montelukast, marketed as Singulair, Merck & Co.'s number-one-selling drug. [read post]
10 Jun 2009, 6:05 am
Zambri, Esquire and Catherine Bertram, Esquire Bloomberg News reports that "Merck & Co. and Schering-Plough Corp. were sued by a Pennsylvania fund for active and retired state employees over claims they misled consumers into paying too much for prescriptions of Zetia [ezetimibe] and Vytorin cholesterol pills. [read post]
3 Jun 2009, 5:49 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Singulair (Montelukast) – US: Merck & Co’s Singulair patent challenged on $50K bounty (Patent Baristas) (GenericsWeb)   General Docs at BIO (Panel addresses narrowing scope of biotech patents – Patent Docs), (‘Perfect storm’ super session – Patent… [read post]
3 Jun 2009, 5:49 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Singulair (Montelukast) – US: Merck & Co’s Singulair patent challenged on $50K bounty (Patent Baristas) (GenericsWeb)   General Docs at BIO (Panel addresses narrowing scope of biotech patents – Patent Docs), (‘Perfect storm’ super session – Patent… [read post]
31 May 2009, 2:37 am
Patent and Trademark Office has ordered a re-examination of a key patent for Merck & Co.'s blockbuster Singulair allergy and asthma drug, saying new questions have been raised about its "patentability. [read post]
27 May 2009, 6:59 am
Jurist reports:The US Supreme Court on Tuesday granted certiorari in Merck & Co. v. [read post]
27 May 2009, 12:58 am
Supreme Court Picks Up Merck Appeal in Vioxx Suit The National Law Journal The Supreme Court on Tuesday agreed to hear Merck & Co.'s challenge to a shareholder suit linked to litigation over the painkiller Vioxx. [read post]
26 May 2009, 1:38 pm
The Wall Street Journal (5/23, Miller) reported, "Johnson & Johnson faces civil lawsuits regarding the antibiotic Levaquin [levofloxacin] filed by one of the most prominent plaintiff's attorneys involved in the suits over Merck & Co.'s Vioxx [rofecoxib] painkiller. [read post]
26 May 2009, 10:02 am
The Supreme Court accepted cert in a securities fraud action from the Third Circuit today, In re Merck & Co. [read post]
26 May 2009, 7:07 am
Docket: 08-905 Title: Merck & Co., Inc., et al., Petitioners v. [read post]
26 May 2009, 7:03 am
  The Justices granted review of Merck & Co., et al., v. [read post]
26 May 2009, 2:55 am
Investors brought a class action suit against the drug maker Merck & Co. [read post]
19 May 2009, 2:36 am
"The lawsuit also claims that Elkin attempted to sell the software to Merck & Co., Inc. [read post]